Clinical Trials Directory

Trials / Completed

CompletedNCT03174821

Effect Insulin Pump Therapy to Patients With Diabetic Nephropathy

The Impact of Insulin Pump Therapy to Oxidative Stress in Patients With Diabetic Nephropathy

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
160 (actual)
Sponsor
Chinese PLA General Hospital · Academic / Other
Sex
All
Age
18 Years – 70 Years
Healthy volunteers
Accepted

Summary

The recent study suggested that oxidative stress resulting from increased production of reactive oxygen species (ROS) plays a crucial role in the development of diabetic complications. The researches aim to monitor the level of oxidative stress of patient in different stage of diabetic nephropathy before and after insulin pump therapy.

Detailed description

Worldwidely, about 30% of Type 1 Diabetes Mellitus (T1DM) and 20%-50% of T2DM patients suffered diabetic nephropathy (DN). Oxidative stress resulting from increased production of reactive oxygen species (ROS) plays a crucial role in the development of diabetic complications. Insulin pump therapy is better than subcutaneous injection in terms of the drug safety and effectiveness. The researches aim to monitor the level of oxidative stress of patient in different stage of diabetic nephropathy before and after insulin pump therapy.

Conditions

Interventions

TypeNameDescription
DEVICEInsulin pumpBlood glucose management device

Timeline

Start date
2010-10-20
Primary completion
2014-05-16
Completion
2014-05-16
First posted
2017-06-05
Last updated
2017-06-05

Source: ClinicalTrials.gov record NCT03174821. Inclusion in this directory is not an endorsement.